MedAssets Shares Popped: What You Need to Know (MDAS)

MedAssets Shares Popped: What You Need to Know

Watch stocks you care about

The single, easiest way to keep track of all the stocks that matter...

Your own personalized stock watchlist!

It's a 100% FREE Motley Fool service...

Click Here Now

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of health-care IT services specialist MedAssets (Nasdaq: MDAS ) climbed as high as 12% in intraday trading Monday after its quarterly results topped Wall Street expectations.

So what: Driven by strong growth in all of its segments, MedAssets posted an adjusted profit of $0.23 per share, versus the average analyst estimate of $0.16 per share. The stock has been crushed in 2011, down about 40% over the past six months, so shareholders are naturally hopeful that today's results trigger the start of a prolonged comeback.

Now what: I wouldn't jump into the stock just yet. Unfortunately, management also cut its full-year revenue and low-end earnings outlook today, suggesting that longer-term picture isn't quite as bright as the rally indicates. With the larger, more-established, dividend-paying rival McKesson (NYSE: MCK ) available at a reasonable price, passing on MedAssets seems prudent.

Interested in more info on MedAssets? Add it to your watchlist.

The Steve Jobs Betrayal
You may already know that in the final year of his life, Jobs revealed a stunning betrayal — and told his biographer, "I will spend my last dying breath... and every penny of Apple's $40 billion in the bank to right this wrong." What was it that made Jobs so irate — and why could it make a few in-the-know investors some major profits over the coming months and years?

Enter your email address below to find out what made Jobs so enraged!

Fool contributor Brian Pacampara owns no position in any of the companies mentioned. Motley Fool newsletter services have recommended buying shares of McKesson. Try any of our Foolish newsletter services free for 30 days.

We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Fool's disclosure policy always gets a perfect score.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment icon found on every comment.